Sopheon PLC
29 May 2002
FOR IMMEDIATE RELEASE 29 May 2002
SOPHEON PLC
AGM : TRADING UPDATE AND NEW ORDERS
At the Annual General Meeting of Sopheon plc ('Sopheon'; stock code : SPE) later
today, Chairman, Barry Mence will give shareholders an update on trading
together with details of new orders signed for the company's 'flagship' Accolade
product :
'I am pleased to report that Sopheon continues to make progress towards its goal
of becoming a leading supplier of software and expert services that enable major
corporations to improve critical processes within research and development (R&
D), and in particular to enhance the efficiency and effectiveness of new product
development.
'During 2001 Sopheon developed rapidly, finishing the year with the completion
of the acquisition of Orbital Software Holdings plc, strengthening the group's
product portfolio and finances. Since the end of 2001, we have been successful
in signing new orders for our 'flagship' Accolade product. In April, we
announced new orders from Glatfelter, a global supplier of speciality papers and
engineered products; Acist Medical Systems, a unit of the Italian healthcare
group, Bracco, that designs and manufactures advanced medical injection systems;
and a diversified multinational supplier of engineered materials that we were
unable to name because of confidentiality constraints.
'Today we are announcing two further orders for Accolade. The first is from
Sappi Fine Paper Europe. Sappi Fine Paper is one of the world's leading
producers of coated fine papers for use in catalogues, magazines and annual
reports. Its European business plans initially to deploy Accolade across its R
&D group in Austria, Belgium, the UK, Germany and the Netherlands. The second
order is linked to a phase II rollout within one of our launching customers from
2001, extending its Accolade user community to 435 seats.
'With interest in Accolade continuing to gather pace in the first quarter,
coupled with the planned and ongoing reduction on bespoke project activities,
the revenue mix within our Business Process Solutions (BPS) division is showing
an increased proportion linked to our higher margin software products. First
quarter success rates for new sales of our Information Management (IM) services
have also shown improvement over the difficult second half of 2001. While these
successes represent real progress, it is too soon to be certain that they will
accelerate into a trend through the year. Accordingly the Board has continued
to maintain pressure on the cost base, seeking reductions wherever possible
whilst retaining the ability to develop and promote our core products and
services, and to capitalise on the market opportunities available to us. With
the corporate developments of the last two years under our belt, all efforts
continue to be concentrated on execution of our plan and in particular, revenue
growth. The reorganisation of the business at the turn of the year into the IM
and BPS divisions has improved the clarity of our offering to the market. Our
sales pipeline has continued to build and our recent successes give us
confidence that 2002 will be another year of significant development for
Sopheon.'
About Sopheon
Sopheon (LSE:SPE) is an international provider of software and services that
enable organizations to more efficiently access internal and external
information and turn it into the knowledge to compete. Sopheon serves nearly
half of the technology-driven companies on the Fortune 500, providing
process-specific software applications that are pre-loaded with specialized
content and access to human expertise. They include the Web-enabled Sopheon
Accolade(R) product development system, the award-winning Teltech.com(R)
Web-based research portal for technical and business professionals, and Organik
(R) expertise-sharing software. Sopheon's European headquarters are in
Guildford in the U.K., and its U.S. headquarters are in Minneapolis. The
company also has operating bases in Germany, the Netherlands and Scotland.
Sopheon is listed on the Alternative Investment Market of the London Stock
Exchange and on Euronext in the Netherlands. For more information, please visit
www.sopheon.com.
For further information contact :
Barry Mence, Chairman Sopheon plc Tel : + 44 (0)1483-883000
Arif Karimjee, CFO Sopheon plc Tel : + 44 (0)1483-883000
Steve Liebmann Buchanan Communications Tel : + 44 (0)207-466-5000
Barbara Jansen Citigate First Financial Tel : + 31 (0)205-754-010
This information is provided by RNS
The company news service from the London Stock Exchange
FLTERITFIF
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.